Germany - Drugs
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 01 May 2024
- Opportunity publication date
- 13 April 2022
- Category
- 33600000: Ph
- Value of contract
- £0-100k
- Your guide to exporting
Description
This notice does not concern the award of a public contract within the meaning of the Public Procurement Coordination Directive (2014/24/EU) or antitrust law. In the interest of providing the broadest possible information to interested pharmaceutical companies, this notice is published in the Supplement to the Official Journal of the European Union. The procedural designation "open procedure" (Section IV.1.1) used in the text of this announcement is due to the requirements of the announcement form. Neither this nor the use of the "TED" medium is associated with any submission to procurement law regulations, the application of which is not mandatory by virtue of the law or procurement regulations. This is a framework agreement with an option to join, which relates to various active ingredients.
The subject of the agreement are drugs containing the active ingredient lenalidomide.
- Opportunity closing date
- 01 May 2024
- Value of contract
- £0-100k
About the buyer
- Address
- BARMER Lichtscheider Str. 89 Wuppertal 42285 Germany
- Contact
- rabattvertraege@barmer.de
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.